» Articles » PMID: 18360573

Antimicrobial Biocides in the Healthcare Environment: Efficacy, Usage, Policies, and Perceived Problems

Overview
Publisher Dove Medical Press
Date 2008 Mar 25
PMID 18360573
Citations 47
Authors
Affiliations
Soon will be listed here.
Abstract

Biocides are heavily used in the healthcare environment, mainly for the disinfection of surfaces, water, equipment, and antisepsis, but also for the sterilization of medical devices and preservation of pharmaceutical and medicinal products. The number of biocidal products for such usage continuously increases along with the number of applications, although some are prone to controversies. There are hundreds of products containing low concentrations of biocides, including various fabrics such as linen, curtains, mattresses, and mops that claim to help control infection, although evidence has not been evaluated in practice. Concurrently, the incidence of hospital-associated infections (HAIs) caused notably by bacterial pathogens such as methicillin-resistant Staphylococcus aureus (MRSA) remains high. The intensive use of biocides is the subject of current debate. Some professionals would like to see an increase in their use throughout hospitals, whereas others call for a restriction in their usage to where the risk of pathogen transmission to patients is high. In addition, the possible linkage between biocide and antibiotic resistance in bacteria and the role of biocides in the emergence of such resistance has provided more controversies in their extensive and indiscriminate usage. When used appropriately, biocidal products have a very important role to play in the control of HAIs. This paper discusses the benefits and problems associated with the use of biocides in the healthcare environment and provides a constructive view on their overall usefulness in the hospital setting.

Citing Articles

Adverse outcome pathway-based assessment of pulmonary toxicity from the mixture of biocides dinotefuran and cetylpyridinium chloride.

Cho Y, Song M, Kim D, Kim M, Lee K Heliyon. 2025; 11(2):e42134.

PMID: 39925360 PMC: 11804698. DOI: 10.1016/j.heliyon.2025.e42134.


Highly Effective Biocides against Reveal New Mechanistic Insights Across Gram-Negative Bacteria.

Sanchez C, Vargas-Cuebas G, Michaud M, Allen R, Morrison-Lewis K, Siddiqui S ACS Infect Dis. 2024; 10(11):3868-3879.

PMID: 39440866 PMC: 11555683. DOI: 10.1021/acsinfecdis.4c00433.


Differential Selection for Survival and for Growth in Adaptive Laboratory Evolution Experiments With Benzalkonium Chloride.

Schmidt S, Taschner T, Nordholt N, Schreiber F Evol Appl. 2024; 17(10):e70017.

PMID: 39399585 PMC: 11470201. DOI: 10.1111/eva.70017.


The mobilome landscape of biocide-resistance in Brazilian ESKAPE isolates.

da Rosa E, Kremer F Braz J Microbiol. 2024; 55(4):3603-3616.

PMID: 39028534 PMC: 11712051. DOI: 10.1007/s42770-024-01450-7.


Current insights into the effects of cationic biocides exposure on spp.

Pereira A, Antunes P, Peixe L, Freitas A, Novais C Front Microbiol. 2024; 15:1392018.

PMID: 39006755 PMC: 11242571. DOI: 10.3389/fmicb.2024.1392018.


References
1.
Bloomfield S . Significance of biocide usage and antimicrobial resistance in domiciliary environments. J Appl Microbiol. 2002; 92 Suppl:144S-57S. View

2.
Pajkos A, Vickery K, Cossart Y . Is biofilm accumulation on endoscope tubing a contributor to the failure of cleaning and decontamination?. J Hosp Infect. 2004; 58(3):224-9. DOI: 10.1016/j.jhin.2004.06.023. View

3.
Rutala W, Weber D . Surface disinfection: should we do it?. J Hosp Infect. 2002; 48 Suppl A:S64-8. DOI: 10.1016/s0195-6701(01)90017-9. View

4.
Lyon B, Skurray R . Antimicrobial resistance of Staphylococcus aureus: genetic basis. Microbiol Rev. 1987; 51(1):88-134. PMC: 373094. DOI: 10.1128/mr.51.1.88-134.1987. View

5.
Longo L . [The etiology, concept and prevention of childbed fever. 1861]. Am J Obstet Gynecol. 1995; 172(1 Pt 1):236-7. View